Answer
Long-term ergot-derived dopamine agonist treatment can rarely cause fibrotic heart-valve changes. Echocardiography checks for existing or new changes.
Sources for this answer
- Cabergoline 0.5mg Tabletsemc · SmPC Current selected SmPC · Version 2
- UK GovernmentUK Government · Reputable Web